Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
J Nucl Med. 2012 May;53(5):723-30. doi: 10.2967/jnumed.111.097600. Epub 2012 Apr 9.
In myocardial perfusion SPECT, transient ischemic dilation ratio (TID) is a well-established marker of severe ischemia and adverse outcome. However, its role in the setting of (82)Rb PET is less well defined.
We analyzed 265 subjects who underwent clinical rest-dipyridamole (82)Rb PET/CT. Sixty-two subjects without a prior history of cardiac disease and with a normal myocardial perfusion study had either a low or a very low pretest likelihood of coronary artery disease or negative CT angiography. These subjects were used to establish a reference range of TID. In the remaining 203 patients with an intermediate or high pretest likelihood, subgroups with normal and abnormal TID were established and compared with respect to clinical variables, perfusion defect scores, left ventricular function, and absolute myocardial flow reserve. Follow-up was obtained for 969 ± 328 d to determine mortality by review of the social security death index.
In the reference group, TID ratio was 0.98 ± 0.06. Accordingly, a threshold for abnormal TID was set at greater than 1.13 (0.98 + 2.5 SDs). In the study group, 19 of 203 patients (9%) had an elevated TID ratio. Significant differences between subgroups with normal and abnormal TID ratio were observed for ejection fraction reserve (5.0 ± 6.4 vs. 1.8 ± 7.9; P < 0.05), difference between end-systolic volume (ESV) at rest and stress (ΔESV[stress-rest]; 1.8 ± 7.4 vs. 12.3 ± 13.0 mL; P < 0.0001), difference between end-diastolic volume (EDV) at rest and stress (ΔEDV[stress-rest]; 10.8 ± 11.5 vs. 23.8 ± 14.6 mL; P < 0.0001), summed rest score (1.8 ± 3.8 vs. 3.8 ± 7.6; P < 0.05), summed stress score (3.0 ± 5.4 vs. 7.5 ± 9.8; P < 0.002), summed difference score (1.3 ± 2.6 vs. 3.7 ± 5.3; P < 0.02), and global myocardial flow reserve (2.1 ± 0.8 vs. 1.7 ± 0.6; P < 0.02). Additionally, TID-positive patients had a significantly lower overall survival probability (P < 0.05). In a subgroup analysis of patients without regional perfusion abnormalities, TID-positive patients' overall survival probability was significantly smaller (P < 0.03), and TID was an independent predictor (exponentiation of the B coefficients [Exp(b)] = 6.22; P < 0.009) together with an ejection fraction below 45% (Exp[b] = 6.16; P < 0.002).
The present study suggests a reference range of TID for (82)Rb PET myocardial perfusion imaging that is in the range of previously established values for SPECT. Abnormal TID in (82)Rb PET is associated with more extensive left ventricular dysfunction, ischemic compromise, and reduced global flow reserve. Preliminary outcome analysis suggests that TID-positive subjects have a lower overall survival probability.
在心肌灌注 SPECT 中,短暂性缺血扩张比(TID)是严重缺血和不良预后的一个既定标志物。然而,其在(82)Rb PET 中的作用还不太明确。
我们分析了 265 例接受临床静息二吡啶并哒(82)Rb PET/CT 的患者。62 例无心脏病病史且心肌灌注研究正常的患者,其冠状动脉疾病的预先可能性较低或非常低,或 CT 血管造影呈阴性。这些患者用于建立 TID 的参考范围。在其余 203 例具有中等或高预先可能性的患者中,建立了 TID 正常和异常的亚组,并比较了临床变量、灌注缺陷评分、左心室功能和绝对心肌血流储备。通过查阅社会安全死亡指数,获得了 969 ± 328 天的随访时间以确定死亡率。
在参考组中,TID 比值为 0.98 ± 0.06。因此,将异常 TID 的阈值设定为大于 1.13(0.98 + 2.5 标准差)。在研究组中,203 例患者中有 19 例(9%)TID 比值升高。TID 比值正常和异常亚组之间存在显著差异,包括射血分数储备(5.0 ± 6.4 比 1.8 ± 7.9;P < 0.05)、收缩末期容积(ESV)在休息和应激时的差异(ΔESV[应激-休息];1.8 ± 7.4 比 12.3 ± 13.0 mL;P < 0.0001)、舒张末期容积(EDV)在休息和应激时的差异(ΔEDV[应激-休息];10.8 ± 11.5 比 23.8 ± 14.6 mL;P < 0.0001)、静息总和评分(1.8 ± 3.8 比 3.8 ± 7.6;P < 0.05)、应激总和评分(3.0 ± 5.4 比 7.5 ± 9.8;P < 0.002)、总和差异评分(1.3 ± 2.6 比 3.7 ± 5.3;P < 0.02)和整体心肌血流储备(2.1 ± 0.8 比 1.7 ± 0.6;P < 0.02)。此外,TID 阳性患者的总生存概率显著降低(P < 0.05)。在无局部灌注异常的患者亚组分析中,TID 阳性患者的总生存概率明显较小(P < 0.03),并且 TID 是独立的预测因子(B 系数的指数[Exp(b)] = 6.22;P < 0.009),同时伴有射血分数低于 45%(Exp[b] = 6.16;P < 0.002)。
本研究提出了(82)Rb PET 心肌灌注成像中 TID 的参考范围,该范围与之前的 SPECT 建立的范围一致。(82)Rb PET 中的异常 TID 与更广泛的左心室功能障碍、缺血性损害和降低的整体血流储备有关。初步结果分析表明,TID 阳性患者的总生存概率较低。